This vial contains 30mg of Retatrutide (LY3437943), a potent tri-agonist peptide that activates GLP-1, GIP, and glucagon receptors. BulkGLP sources raw compound, verifies purity through third-party HPLC testing, and prepares each vial in-house without excipients or stabilizers.
Our clean, unbuffered preparation offers researchers a consistent material for controlled studies of metabolic and receptor-based pathways.
Potency Advisory:
This compound is prepared without mannitol or other excipients that may buffer or dilute absorption in research settings. BulkGLP receives raw Retatrutide powder and prepares vials in-house, preserving the compound’s integrity and concentration.
Researchers may observe significantly stronger uptake and faster receptor activation compared to diluted or pre-formulated sources.
Always begin with microdose-level trials to assess response. Do not assume equivalence to externally sourced materials.
Appearance Note:
This product contains pure lyophilized Retatrutide with no mannitol, sugars, or bulking agents added. As a result, the powder may appear broken, collapsed, or partially dispersed within the vial. This is normal for unbuffered compounds and does not affect integrity or purity.
⚠️ Pure peptides without excipients do not always form a solid "cake" during lyophilization.
What you're seeing is real compound, not filler.
Specifications:
-
Compound: Retatrutide (GLP-1/GIP/GCG Tri-Agonist)
-
Catalog Number: RETA-30MG-1
-
CAS Number: 2381089-83-2
-
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
-
Molecular Weight: ~4731.33 g/mol
-
Quantity: 30mg
-
Appearance: White powder
-
Purity: >98.5% (verified by third-party HPLC)
-
Preparation: No mannitol. No buffers. No fillers.
-
Storage:
-
Lyophilized: Store at -20°C or colder
-
After reconstitution: Refrigerate at 36–46°F (2–8°C)
-
Avoid repeated freeze-thaw cycles
-
Research Applications:
Designed for laboratory research involving GLP-1, GIP, and glucagon receptor agonism. For use in metabolic, receptor signaling, and obesity-related studies.
Disclaimer:
For research use only. Not for human or veterinary use. BulkGLP does not operate as a compounding pharmacy or 503B facility. This compound is not intended to diagnose, treat, or prevent any disease.
